PRCT News and Press, PROCEPT BioRobotics Corporation From 08/17/23

REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will pre...

EVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics ® announce a significant milestone in access to treatment of Benign Prostatic Hyperplasia (BPH). NorthShore’s Highland Park Hospital has become the first hospi...

2023-08-11 16:59:33 ET Piper Sandler initiated coverage of Procept BioRobotics ( NASDAQ: PRCT ) with a overweight rating, citing the growth potential for its AquaBeam robotic system for the treatment of benign prostatic hyperplasia, or enlarged prostate. Piper said that the Aqua...

2023-08-10 15:24:25 ET Summary PRCT's aquablation therapy has shown strong growth, with revenues of $57.5mm in Q2 FY'23. The company's economic levers include new system placements, and growth from its installed base, with a record number of systems placed in Q2. Net-net, reit...

2023-08-02 08:34:07 ET PROCEPT BioRobotics ( NASDAQ: PRCT ) has announced the pricing of an upsized underwritten public offering of 4.42M shares of its common stock at a public offering price of $33.92/share, for aggregate gross proceeds of ~$150M . In addition, the Co. ha...

REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the pricing of an up...

2023-08-01 17:47:40 ET PROCEPT BioRobotics ( NASDAQ: PRCT ) plans to raise $125 million through an underwritten public offering of shares of its common stock, the company said Tuesday. The underwriters have a 30-day option to purchase up to an additional $18.75 million in shar...

REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the commencement of ...

2023-07-28 17:23:13 ET PROCEPT BioRobotics Corporation (PRCT) Q2 2023 Earnings Conference Call July 27, 2023, 08:00 AM ET Company Participants Matt Bacso - VP, IR and Business Operations Reza Zadno - President and CEO Kevin Waters - EVP and CFO Conference C...

2023-07-27 08:56:51 ET Procept press release ( NASDAQ: PRCT ): Q2 GAAP EPS of -$0.56. Revenue of $33.1M (+98.3% Y/Y). For further details see: Procept GAAP EPS of -$0.56, revenue of $33.1M